home / United States / Novavax

Novavax Market Cap

$1.03 B

-3.22 M

NASDAQ:NVAX · April 16, 2025

Share price

$6.39

Enterprise Value

$0.37 B

Change (1-Year)

110.5%

Global Rank

#5007

Country Rank

#1812

Regions

USA

Market cap

As of April 16, 2025, Novavax (NVAX) has a market cap of $1.03 billion USD. According to our data, Novavax is ranked No.5007 in global market value.

Sector Rank:

Biotech #257 Pharmaceuticals #238

NVAX Market Capitalization Growth

1 Years Growth:

110.5%

3 Years Growth:

-85.2%

5 Years Growth:

-57.1%

10 Years Growth:

-94.9%

15 Years Growth:

-83.9%

20 Years Growth:

-69.7%

Total Growth:

-89%

Novavax Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Novavax Market Cap CAGR Chart

Novavax Market Cap History 1995 - 2025

Year	Market Cap	%Change
Apr 16, 2025	$1.03 B	-20.20%
Dec 31, 2024	$1.29 B	67.50%
Dec 29, 2023	$0.77 B	-53.31%
Dec 30, 2022	$1.65 B	-92.81%
Dec 31, 2021	$22.92 B	28.30%
Dec 31, 2020	$17.86 B	2,701.76%
Dec 31, 2019	$0.64 B	-89.18%
Dec 31, 2018	$5.89 B	48.39%
Dec 29, 2017	$3.97 B	-1.59%
Dec 30, 2016	$4.04 B	-84.98%
Dec 31, 2015	$26.88 B	41.48%
Dec 31, 2014	$19.00 B	15.82%
Dec 31, 2013	$16.40 B	170.90%
Dec 31, 2012	$6.05 B	50.00%
Dec 30, 2011	$4.04 B	-48.15%
Dec 31, 2010	$7.78 B	-8.65%
Dec 31, 2009	$8.52 B	40.74%
Dec 31, 2008	$6.05 B	-43.24%
Dec 31, 2007	$10.67 B	-18.78%
Dec 29, 2006	$13.14 B	6.49%
Dec 30, 2005	$12.33 B	18.10%
Dec 31, 2004	$10.44 B	-45.67%
Dec 31, 2003	$19.22 B	130.77%
Dec 31, 2002	$8.33 B	-81.56%
Dec 31, 2001	$45.17 B	65.88%
Dec 29, 2000	$27.23 B	51.11%
Dec 31, 1999	$18.02 B	190.32%
Dec 31, 1998	$6.21 B	-61.25%
Dec 31, 1997	$16.02 B	45.45%
Dec 31, 1996	$11.01 B	-8.33%
Dec 29, 1995	$12.01 B	100%

Similar Companies to Novavax

Name	Market Cap	Market cap difference	Regions
Pfizer PFE	$127.27 B	-0.003 M	USA
Moderna MRNA	$10.14 B	-0.001 M	USA
Johnson & Johnson JNJ	$370.20 B	0.003 M	USA
AstraZeneca AZN	$210.42 B	-0.005 M	UK
GlaxoSmithKline GSK	$72.33 B	-0.002 M	UK
Sanofi SNY	$123.58 B	-0.002 M	France
Merck MRK	$197.26 B	0.003 M	USA
BioNTech BNTX	$23.80 B	0.001 M	Germany
Curevac CVAC	$0.73 B	0.000 M	Germany
Dynavax Technologies DVAX	$1.42 B	-0.000 M	USA
Inovio Pharmaceuticals INO	$64.55 M	0.000 M	USA
Vaxart VXRT	$81.11 M	-0.000 M	USA
Arcturus Therapeutics ARCT	$0.29 B	0.000 M	USA
Valneva SE VALN	$0.57 B	0.000 M	France

About Novavax Inc.

Name

Novavax, Inc.

Website

https://global.novavax.com

Headquarters

Gaithersburg,MD

symbol

NVAX

CURRENCY

USD

country

United States

fullTimeEmployees

952

exchange

NMS

firstTradeDateEpochUtc

1969/12/31

NVAX Market Cap Formula

Market Cap	=	NVAX Stock Price	*	NVAX Shares Outstanding
	=	$6.39	*	0.16 B
	=	$1.03 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe